Physicians and scientists in the Lurie Cancer Center’s OncoSET program are teaming up to help pioneer precision oncology.
Deputy Director Maha Hussain, MD oversees clinical research at the Lurie Cancer Center, but never forgets her primary goal: having an impact on patients.
Scientists have developed software that can forecast the survival of patients diagnosed with glioma that is more accurate than physicians’ predictions.
Maha Hussain, MD, recently published several papers detailing new findings in metastatic castration-resistant prostate cancer treatment and prostate cancer screening.
Daycares and early childhood education programs frequently use spray sunscreen on children, but still have room for improvement when it comes to sun safety, according to a new Northwestern Medicine study.
A drug originally designed for chemotherapy may reduce allergic responses for a variety of allergens, according to a study published in the Journal of Allergy and Clinical Immunology.
Patients with an advanced form of kidney cancer have similar quality of life outcomes on a therapy called cabozantinib, compared to those on a standard treatment.
Scientists throughout Feinberg are deeply invested in identifying health disparities — those differences in health outcomes between populations — as well as exploring novel interventions.
Northwestern Medicine scientists have discovered why Huntington’s disease is so toxic to cancer cells and have harnessed it for a novel approach to treat cancer.